Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R R Ellison

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Cancer Chemotherapy Reports|April 1, 1971
Failure of hydroxyurea (NSC-32065) and prednisone (NSC-10023) in the treatment of acute myelocytic leukemiaF Rosner, O Glidewell, R R Ellison, et al.
Cancer|November 1, 1975
Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemiaR W Carey, M Ribas-Mundo, R R Ellison, et al.
Cancer Research|May 1, 1973
Daunorubicin in the therapy of acute granulocytic leukemiaM Weil, O J Glidewell, C Jacquillat, et al.
Blood|August 1, 1982
Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB studyJ Yates, O Glidewell, P Wiernik, et al.
Blood|December 1, 1981
Treatment of acute myelocytic leukemia: a study by cancer and leukemia group BK R Rai, J F Holland, O J Glidewell, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Cancer Chemotherapy Reports|April 1, 1971
Failure of hydroxyurea (NSC-32065) and prednisone (NSC-10023) in the treatment of acute myelocytic leukemiaF Rosner, O Glidewell, R R Ellison, et al.
Cancer|November 1, 1975
Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemiaR W Carey, M Ribas-Mundo, R R Ellison, et al.
Cancer Research|May 1, 1973
Daunorubicin in the therapy of acute granulocytic leukemiaM Weil, O J Glidewell, C Jacquillat, et al.
Blood|August 1, 1982
Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB studyJ Yates, O Glidewell, P Wiernik, et al.
Blood|December 1, 1981
Treatment of acute myelocytic leukemia: a study by cancer and leukemia group BK R Rai, J F Holland, O J Glidewell, et al.
Pageof 4